BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37722316)

  • 21. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
    Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
    PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the
    Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
    J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filamin A Variant as a Possible Second-Hit Gene Promoting Moyamoya Disease-like Vascular Formation Associated With
    Ikeuchi Y; Kitayama J; Sahara N; Okata T; Miyake N; Matsumoto N; Kitazono T; Ago T
    Neurol Genet; 2022 Oct; 8(5):e200017. PubMed ID: 36101542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in Clinical Phenotype, Mutation Position, and Structural Change of RNF213 Rare Variants Between Pediatric and Adult Japanese Patients with Moyamoya Disease.
    Nomura S; Akagawa H; Yamaguchi K; Azuma K; Nakamura A; Fukui A; Matsuzawa F; Aihara Y; Ishikawa T; Moteki Y; Chiba K; Hashimoto K; Morita S; Ishiguro T; Okada Y; Vetiska S; Andrade-Barazarte H; Radovanovic I; Kawashima A; Kawamata T
    Transl Stroke Res; 2023 Sep; ():. PubMed ID: 37768541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.
    Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
    Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
    Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
    Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
    Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
    Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
    Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
    Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Oct; 439(4):419-26. PubMed ID: 23994138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renovascular hypertension and
    Kim JY; Cho H
    Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of
    Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J
    Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.
    Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J
    J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Shin HS; Park GH; Choi ES; Park SY; Kim DS; Chang J; Hong JM
    J Cereb Blood Flow Metab; 2024 Apr; ():271678X241245557. PubMed ID: 38573771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease.
    Liu SM; Gao G; Hao FB; Liu ST; Yang RM; Zhang HD; Wang MJ; Zou ZX; Yu D; Zhang Q; Guo QB; Wang XP; Fu HG; Li JJ; Han C; Duan L
    Stroke Vasc Neurol; 2024 Mar; ():. PubMed ID: 38460971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.